Press release
67KB
april 08, 2021 - Philips
Philips and Ibex Medical Analytics team to accelerate adoption of AI-powered digital pathology
- Philips and Ibex Medical Analytics cooperate to globally commercialize clinically proven, AI-powered digital pathology solutions
- Combination of Philips’ digital pathology solutions and Ibex’s AI-powered Galen platform has improved reporting efficiency by 27%, driven 37% productivity gains, and improved consistency and accuracy to enhance diagnostic confidence
- Collaboration furthers Philips’ commitment to integrated diagnostics providing a clear path to precision diagnosis
Amsterdam, The Netherlands and Tel Aviv, Israel – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in #health technology, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, today announced a strategic #collaboration to jointly promote their digital pathology and AI solutions to hospitals, #health networks and pathology labs worldwide. The combination of #philips digital pathology solution (Philips IntelliSite Pathology Solution) and Ibex’s Galen™ AI-powered cancer diagnostics platform [1], currently in clinical use in Europe and the Middle East, empowers pathologists to generate objective, reproducible results, increase diagnostic confidence, and enable the productivity and efficiency improvements needed to cope with ever-increasing demand for pathology-based diagnostics.
Today’s announcement marks the latest extension to Philips’ AI-enabled Precision Diagnosis solutions portfolio, which leverages #philips and third-party AI solutions to deliver cutting-edge clinical decision support and optimized workflows that enable healthcare providers to deliver on the Quadruple Aim of better patient outcomes, improved patient and staff experiences, and lower cost of care.
The trend towards centralized pathology labs, the global shortage of trained pathologists, and increasing demands on histopathology posed by the growing number of cancer patients, leads pathology labs to actively seek efficiency-enhancing solutions that enable to maintain high accuracy levels. Digital pathology, enabled by solutions such as #philips IntelliSite Pathology Solution has already been shown to improve pathology lab productivity by 25% [2], while also allowing remote image reading by specialists and the immediate sharing of images with referring hospitals as part of comprehensive pathology reports. Ibex’s AI-powered Galen platform further streamlines workflow and improves accuracy via automated case prioritization, cancer heatmaps, grading and other productivity-enhancing tools.
Further information in the press release to download
Related news |
||
|
|
|
february 29, 2024
|
february 28, 2024
|
february 27, 2024
|
|
New CT 5300 system provides more accurate and reliable imaging results to better manage increase in complex cardiac cases where pr... |
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the proposal to appoint Charlotte Hann... |
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced major enhancements to its Image Guided... |
Download all 
You might be interested in |
||
|
|
|
february 20, 2024
|
february 07, 2024
|
january 31, 2024
|
|
1.88 billion lives improved by Philips’ health technology products and services; on track to improve 2 billion lives by 2025 Throu... |
FDA 510(k) clearance of latest Philips IntelliVue patient monitor software helps drive alarm management strategies toward a more ... |
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its latest TEE transducer, design... |
Italian 
Download all 
Share
Share via mail 
Automotive
Sport
Events
Art&Culture
Design
Fashion&Beauty
Food&Hospitality
Technology
Nautica
Racing
Excellence
Corporate
OffBeat
Green
Gift
Pop
Heritage
Entertainment
Health & Wellness